Mercer Global Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$513K Sell
4,807
-925
-16% -$112K ﹤0.01% 2272
2026
Q1
$937K Buy
5,732
+165
+3% +$25.4K ﹤0.01% 1599
2025
Q4
$969K Buy
5,567
+2,045
+58% +$373K ﹤0.01% 1474
2025
Q3
$507K Buy
3,522
+1,098
+45% +$135K ﹤0.01% 1749
2025
Q2
$244K Buy
+2,424
New +$185K ﹤0.01% 1970
2025
Q1
Sell
-3,281
Closed -$227K 2208
2024
Q4
$227K Buy
+3,281
New +$236K ﹤0.01% 1901

Other funds holding INSM

Mercer Global Advisors's INSM Position: Q2 2026 in Review

Mercer Global Advisors reduced its Insmed (INSM) stake by 16% in Q2 2026, selling an estimated $112K and leaving 4,807 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #2272.

Mercer Global Advisors first reported a position in INSM in Q4 2024 and has held it in 6 quarters since. The position peaked at $969K in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Mercer Global Advisors held 4,807 shares of Insmed worth $513K as of Q2 2026.
  • Mercer Global Advisors sold 925 Insmed shares in Q2 2026, an estimated $112K.
  • Insmed made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2272 holding.
  • Mercer Global Advisors first reported a position in Insmed in Q4 2024 and has held it in 6 quarters since.
  • Mercer Global Advisors's Insmed position peaked at $969K in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.